News & Articles

Join SelectScience and Dr. Richard Eglan for a specialist drug discovery webinar on 3D cell culture technology

Learn how a company in Switzerland is harnessing the latest cell culture technology to build even more predictive 3D cellular models for respiratory disease research

Dr. Ivan Cornella-Taracido, of Cedilla Therapeutics, discusses his work looking for therapeutic targets by harnessing protein homeostasis, and shares his insights into the future of drug discovery

An expert cellular biologist answers your questions on cell subset identification in studying heterogeneous populations of cells

Applications now open for the Eppendorf Award for Young European Investigators

AutoScratch tool to facilitate 2D collective cell migration and invasion applications

Attend this free webinar to discover new imaging technology that enables true 3D high content analysis

Discover the dedicated sessions on offer for early careers professionals at ELRIG Drug Discovery 2018

Your solution for quick and easy filtration of single-cell suspensions

Discover a comprehensive guide to real-time live-cell imaging and analysis

Ready-to-use immunoassay kit designed to increase productivity

Researchers reveal new insights into self repair pathways in cancer cells, after therapy with PARP inhibitors

Discover how scientists in Sweden and Finland are developing a functional systems precision medicine strategy to optimize treatment of acute myeloid leukemia

New 3D model provides options for drug development and treatment of gestational disorders

World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance

The findings could help clinicians decide the best course and delivery of treatment for cancer patients

A laboratory in the US is using advanced imaging to decipher the role of a ‘double-agent’ protein in breast cancer, and to help develop drugs targeted at disrupting its function

CRISPR-Cas9 found to induce p53 expression in cells

The Oncomine TCR Beta-SR Assay for next-generation sequencing enables site-specific interrogation for T-cell receptor applications